Market Scenario 

The Global Diagnostics Market report, analyzed by Astute Analytica, examines the tuberculosis, asthma, sepsis, and pneumonia diagnostics market for the study period 2017-2030. 

The Global Tuberculosis Diagnostics Market is projected to reach US$ 4,480.7 Mn by 2030 from US$ 2,984.8 Mn in 2021, registering a CAGR of 4.7% during 2022-2030. 

The Global Asthma Diagnostics Market was valued at US$ 3,385.5 Mn in 2021 and is forecasted to reach US$ 5,857.7 Mn by 2030, registering a CAGR of 6.5% over the projection period. 

The Global Sepsis Diagnostics Market is witnessing a CAGR of 8.4% during 2022-2030. The Sepsis Diagnostics Market is estimated to witness a growth in its revenue from US$ 489.3 Mn in 2021 to US$ 992.8 Mn by 2030. Further, the Global Pneumonia Diagnostics Market is anticipated to experience a leap forward in its revenue from US$ 460.9 Mn in 2021 to US$ 828.5 Mn by 2030, recording a growth rate of 6.9% over the forecast period. The diagnostics market is majorly driven by factors such as an increase in prevalence of chronic and infectious diseases and availability of point-of-care testing kits. 

Infectious diseases are on the rise across the world. According to WHO (World Health Organization), a total of 1.5 million people died from TB in 2020. Worldwide, TB is the 13th leading cause of death and the second leading infectious killer after COVID-19. TB occurs in every part of the world. In 2020, the largest number of new TB cases occurred in the WHO South-East Asian region, with 43% of new cases, followed by the WHO African region, with 25% of new cases. Further, asthma is a major non-communicable disease affecting both children and adults. According to the data presented by WHO, asthma affected an estimated 262 million people in 2019 and caused 4,55,000 deaths. Sepsis is a syndromic response to infection and is frequently a final common pathway to death from many infectious diseases worldwide. According to recent studies, sepsis kills 11 million people each year, many of them children. It disables millions more. In addition, Pneumonia is the single largest infectious cause of death in children worldwide. Pneumonia accounts for 14% of all deaths of children under 5 years old in 2019. Moreover, the availability of point of care testing kits such as lateral flow assays is propelling the market growth. However, stringent regulatory approvals may affect market growth.

Key Insights of the Report: 

• The latest study published by Astute Analytica analyzes the Global Diagnostics Market for the study period of 2017-2030; where the historical years are 2017-2020, the base year is 2021, and the forecast period is 2022-2030.
• The research report offers a detailed study of market determinants including market drivers, restraints, opportunities, and trends; along with an attractive presentation in the form of impact analysis to gain a simpler and easy comparison view of all market determinants.
• The research study is a compilation of 9 chapters distributed across 261 pages with 49 lists of tables and 129 lists of figures.
• The market report presents the study of the Global Tuberculosis Diagnostics Market, Global Asthma Diagnostics Market, Global Sepsis Diagnostics Market, and Global Pneumonia Diagnostics Market. Further, each market is sub-segmented based on test type, end-users, and region.
• The market estimates are presented in terms of value (US$ Mn).
• Along with market estimations, the market study was conducted on the basis of various economic models such as PESTLE and Porter’s five force models.
• A detailed value chain analysis of the industry was conducted. It includes raw material providers, diagnostic device manufacturers, distributors, and end-users.
• The competitive dashboard section includes analysis on the basis of Concentration Ratio (CR), based on market size and market presence of key companies.

Market Overview

Global Tuberculosis Diagnostics Market

Asia Pacific holds the highest share of the Global Tuberculosis Diagnostics Market and registers the highest CAGR over the forecast period. This is because the Asia-Pacific region carries the highest share of the global TB burden, including the majority of all estimated multidrug-resistant (MDR)-TB cases. Further, in terms of test type, the diagnostic laboratory method holds the highest market share in 2021. The usage of new technologies like fluorescent microscopy, and liquid cultures for identification and drug sensitivity has made the diagnosis, identification, and drug sensitivity tests fast and reliable, which makes this segment hold the highest share.

Global Asthma Diagnostics Market

The asthma diagnostic market is registering a CAGR of 6.5% over the forecast period. Based on type, allergy tests hold the highest market share in 2021 as they are quick, reliable, and cost-effective. Allergy tests are a way to get to the bottom of what's causing asthma symptoms. Further, in terms of end-users, hospitals are the highest end-users in the asthma diagnostics market in 2021. The Asia Pacific is the highest shareholder region in the Global Asthma Diagnostics Market in 2021.

Global Sepsis Diagnostics Market

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. If not recognized early and managed promptly, it can lead to septic shock, multiple organ failure, and death. North America is the highest shareholder region in the Global Sepsis Diagnostics Market in 2021 whereas Asia Pacific records the highest CAGR over the forecast period. This is because in low- and middle-income countries sepsis represents a major cause of maternal and neonatal morbidity and mortality. In terms of test type, the CRP test holds the highest segmental share in 2021 as CRP is an acute phase reactant and a sensitive biomarker for sepsis. 

Global Pneumonia Diagnostics Market

Blood test holds the highest share in the pneumonia diagnostics market in 2021 as it is one of the initial and common ways to determine the cause of pneumonia in a patient. The segment also registers the highest CAGR over the forecast period. Further, in terms of end-users, hospitals are the highest end-users in the pneumonia diagnostics market in 2021. Further, North America holds the highest market share in 2021. 

Competitive Analysis

The key players in the Global Diagnostics Market are Abbott Laboratories, Thermo Fisher Scientific Inc., Becton Dickenson, Koninklijke Philips N.V., and BioMerieux, among others.

Segmentation Overview

The following are the various segmentation of the Global Diagnostics Market:

Global Tuberculosis Diagnostics Market

By Test Type segment of the Global Tuberculosis Diagnostics Market is sub-segmented into:

• Radiographic Method
• Cytokine Detection Assay
• Nucleic Acid Testing
• Detection of Latent Infection
• Diagnostic Laboratory Method
• Detection of Drug Resistance
• Others

By End User segment of the Global Tuberculosis Diagnostics Market is sub-segmented into:

• Clinics
• Hospitals
• Research Institutes & Academics
• Diagnostic Centers

Global Asthma Diagnostics Market

By Test Type segment of the Global Asthma Diagnostics Market is sub-segmented into:

• Radiographic Method
• Spirometry Test
• Bronchodilator Reversibility Test
• FeNO Test
• Peak Flow
• Bronchial Challenge Tests
• Allergy tests
• Others

By End User segment of the Global Asthma Diagnostics Market is sub-segmented into:

• Clinics
• Hospitals
• Research Institutes & Academics
• Diagnostic Centers

Global Sepsis Diagnostics Market

By Test Type segment of the Global Sepsis Diagnostics Market is sub-segmented into:

• CRP Test
• PT & PTT Test
• Urinalysis
• Pulse Oximetry
• Others

By End User segment of the Global Sepsis Diagnostics Market is sub-segmented into:

• Clinics
• Hospitals
• Research Institutes & Academics
• Diagnostic Centers

Global Pneumonia Diagnostics Market

By Test Type segment of the Global Pneumonia Diagnostics Market is sub-segmented into:

• Blood Test
• Chest X-Ray Test
• Pulse Oximetry
• Sputum Test
• Others

By End User segment of the Global Pneumonia Diagnostics Market is sub-segmented into:

• Clinics
• Hospitals
• Research Institutes & Academics
• Diagnostic Centers